Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
376 employees · est. 2002 · Morristown, United States
Intercept Pharmaceuticals is the older company (2002 vs 2010); Ultragenyx is the larger of the two.
Side-by-Side Comparison
| Metric | Intercept Pharmaceuticals | Ultragenyx |
|---|---|---|
| Founded | ||
| Founded | 2002 older | 2010 |
| Headquarters | ||
| Headquarters | Morristown, United States | Novato, United States |
| Employees | ||
| Employees | 376 | 1535 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $970.05M | $1.14B |
| Funding Rounds | ||
| Funding Rounds | 8 | 6 |
| Services | ||
| Services | Not tracked yet | Development of therapies for rare genetic diseases, Gene therapy solutions, Clinical trials and transparency, Drug modality exploration, Patient advocacy and support |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare and ultra-rare diseases, Healthcare professionals, Patient advocacy groups, Medical researchers, Healthcare investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Liver Diseases, Rare Diseases, Drug Development, Therapeutics, Chronic Autoimmune Liver Diseases, Small Molecule Drugs, Fibrotic Diseases, Metabolic Diseases, Bile Acid Receptors, Chronic Liver Diseases, Non-viral Liver Diseases, Innovation | Rare Diseases, Ultrarare Diseases, Orphan Drugs, Genetic Diseases, Therapeutics Development, Clinical Pipeline, Innovative Medicines, Transformative Therapies, Unmet Medical Needs, Inclusive Culture, Patient-focused, Drug Commercialization, Scientific Research, Product Portfolio |
| Website | ||
| Website | interceptpharma.com | ultragenyx.com |
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, founded in 2002, is a biopharmaceutical company focused on developing novel therapeutics to treat rare and serious liver diseases such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). The company's last investment of $447.70M in Post-IPO...
About Ultragenyx
Ultragenyx, founded in 2010 and headquartered in the United States, is making significant strides in the Biotechnology, Health Care, and Pharmaceutical sectors. With the slogan "Going Beyond Every Day," the company is dedicated to developing innovative therapies for rare and ultra-rare diseases, aim...
We will tell you when either one moves
BounceWatch watches Intercept Pharmaceuticals and Ultragenyx for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Intercept Pharmaceutic... and Ultragenyx — by email.
Frequently Asked Questions
Compare Intercept Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Intercept Pharmaceuticals on 12 Sep 2024, and Ultragenyx on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.